Jun 8, 2026 06:54AM
May 14, 2026 07:10AM
May 14, 2026 07:00AM
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM
Mar 12, 2026 05:14AM
Mar 11, 2026 11:51AM REGENXBIO reports interim data for Duchenne gene therapy RGX-202
Mar 11, 2026 11:45AM
Mar 10, 2026 09:00AM
Mar 9, 2026 07:46AM
Mar 9, 2026 06:49AM
Mar 6, 2026 04:00PM
Mar 5, 2026 02:11PM
Mar 5, 2026 07:05AM REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Mar 3, 2026 09:00AM
Feb 27, 2026 01:10AM
Feb 26, 2026 04:00PM
Feb 26, 2026 11:53AM
Feb 24, 2026 09:00AM
Feb 23, 2026 03:15AM
Feb 20, 2026 04:19AM REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX
Feb 19, 2026 10:15AM
Feb 18, 2026 05:00PM
Feb 16, 2026 10:54AM
Feb 11, 2026 06:40AM
Feb 9, 2026 04:05PM
Feb 9, 2026 04:05PM
Jan 29, 2026 06:50AM H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
Jan 29, 2026 04:44AM
Jan 29, 2026 04:26AM
Jan 28, 2026 01:51PM
Jan 28, 2026 07:30AM
Jan 28, 2026 07:30AM
Jan 12, 2026 06:53AM
Jan 11, 2026 03:00PM REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
Dec 19, 2025 07:44AM
Dec 15, 2025 06:20AM
Nov 6, 2025 07:05AM
Sep 8, 2025 07:14AM
Sep 5, 2025 03:21PM
Sep 5, 2025 11:03AM
Sep 5, 2025 07:05AM REGENXBIO reports sustained biomarker reduction in MPS II gene therapy trial
Sep 5, 2025 07:05AM
Aug 19, 2025 06:48AM
Aug 19, 2025 06:40AM
Aug 18, 2025 05:00PM
Aug 18, 2025 05:00PM
Aug 8, 2025 08:52AM
Aug 7, 2025 07:05AM REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights
Jun 5, 2025 07:05AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All